Maynard Um
-
-
-
-
-
-
-
Beam Therapeutics Inc (BEAM) PT Raised to $47 at Leerink Partners
-
-
-
-
-
-
-
Canaccord Genuity Starts Beam Therapeutics Inc (BEAM) at Buy
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
Beam Therapeutics Inc. (BEAM) Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

